SOSV is a global venture capital firm that supports early-stage startups through active, founder-first development programs. Its flagship initiatives HAX and IndieBio provide facilities, engineering resources, services, and laboratory equipment to accelerate product development and prepare companies for subsequent funding rounds. SOSV focuses on deep technology across health, environmental, and cross-border software sectors, aiming to solve human and planetary health challenges. In addition to providing capital, the firm emphasizes intensive programmatic support to help portfolio companies move quickly from seed toward growth, including customer acquisition and scale. The firm operates globally with a bias toward startups targeting rapid international expansion, especially in Asia, and tends to back a small cohort of high-potential companies to accelerate their progress and attract leading investors.
Hemoalgae is a biotechnology company specializing in the production of anticoagulant hirudin using microalgae. Its applications include treating coronary ischemic syndromes, disseminated intravascular coagulation, extracorporeal circulation, and preventing thrombosis.
Magenta Biolabs
Seed Round in 2016
Magenta Biolabs is a Costa Rica-based company, founded in 2016, that specializes in the production of hyaluronic acid for the cosmetic industry. The company focuses on transforming organic by-products from agricultural and industrial sources into high-quality raw materials. By employing sustainable and environmentally friendly practices, Magenta Biolabs establishes circular supply chains that allow for the continuous reuse and repurposing of materials. This innovative approach not only recycles nutrients but also generates valuable compounds, positioning the company as a leader in the development of natural and sustainable ingredients for cosmetics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.